2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Poster Session

[P53] Poster Session 53 Palliative Care/Symptom Management 2

Daisuke Tsutsumi1,2,3, Tatsuya Hayama1,3, Katsuhiro Miura3,4, Akihiro Uchiike1,3, Shinya Tsuboi1,3, Isamu Odagiri1,2, Takashi Yamauchi1,3, Susumu Ootsuka1, Yoshihiro Hatta4, Yukinaga Kishikawa2 (1.Department of Pharmacy, Nihon University Itabashi Hospital, 2.School of Pharmacy, Nihon University, 3.Nihon University Itabashi Hospital Tumor Center, 4.Division of Hematology and Rheumatology, Department of Medicine, Nihon University)

Takamichi Arima1, Tatsuya Yoshida2, Yuki Takeyasu2, Yasuko Takeda1, Daisuke Watabe1, Mitsunobu Isikawa1, Toru Akagi1, Hironobu Hashimoto1, Ken Masuda2, Yuki Shinno2, Yuji Matsumoto2, Yusuke Okuma2, Yasushi Goto2, Hidehito Horinouchi2, Tetsuya Furukawa1, Noboru Yamamoto2, Yuichiro Ohe2 (1.Department of Pharmacy, National Cancer Center Hospital, 2.Department of Thoracic Oncology, National Cancer Center Hospital)

Kazumasa Yamamoto1, Yuko Tanabe1, Kiyomi Nonogaki1, Hiroki Okumura1, Haruka Ozaki1, Masahiro Kuno1, Shogo Watanabe1, Yosuke Aoyama1, Takahashi Takahashi1, Koichiro Yoshino1, Kohji Takemura1, Taro Yamanaka1, Rika Kizawa1, Takeshi Yamaguchi1, Kiyo Tanaka2, Yoko Kobayashi2, Nobuko Tamura2, Hidetaka Kawabata2, Yuji Miura1, Koichi Suyama1 (1.Department of Medical Oncology, Toranomon Hospital, 2.Department of Breast and Endocrine Surgery, Toranomon Hospital)

Michiyo Kotani1, Ryoji Takada2, Kumiko Fujishima1, Masami Yamada1, Miki Ishibashi3 (1.Department of Nursing Osaka International Cancer Institute, 2.Department of Hepato-biliary Pancreatic Oncology, Osaka International Cancer Institute, 3.Department of Dentistry, Osaka International Cancer Institute)

Katsuya Juso1, Aya Sakabe2, Minako Hiramura2, Ikuko Takagi2, Miyoko Matsuzaki2, Tami Nakao2, Hitomi Miura2, Aya Koganei2, Mami Usuki2, Tomoki Hashimoto2, Natsuki Takasaki2, Yuu Araki2, Hiromi Itou2, Ayaka Ueda2, Yuuto Kuroiwa2, Yumi Amano1, Hiroki Izuno1, Junpei Takeshita1, Takesi Kotake1, Kazuhiro Yanagihara1 (1.Department of Medical Oncology, Kansai Electric Power Hospital, 2.Outpatient chemotherapy unit, Kansai Electric Power Hospital)

Yuki Saito1, Kenro Hirata1,2, Yuka Yamada3, Kazuyuki Tsunoda3, Hiroshi Muramatsu4, Sara Horie1, Yoshimitsu Taguchi1, Tomoko Shimizu1, Shotaro Kishimoto1, Akihiko Chida1, Kai Tsugaru1, Keitaro Shimozaki1, Kazuhiro Togasaki1, Kenta Kawasaki1, Hideyuki Hayashi2, Yasutaka Sukawa1, Makoto Naganuma5, Taneaki Nakagawa3, Yasuo Hamamoto1,2, Takanori Kanai1 (1.Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 2.Keio Cancer Center, Keio University School of Medicine, 3.Department of Dentistry and Oral Surgery, Keio University School of Medicine, 4.Department of Pharmacy, Keio University Hospital, 5.The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University)

Hiroaki Takagi1, Kohei Ogawa1, Kouji Matumori2, Tomohide Omizo2, Takashi Nakasima2, Noriaki Orita2, Fumitaka Arihara2, Kouichirou Matuda2, Mituru Matuda2, Akito Sakai2, Takeshi Thuda3, Hirokazu Taniguchi3, Yuto Kitano4, Atushi Hirose4, Tomoya Thukada4, Hironori Hayashi4, Masahide Kaji4 (1.Department of Medical Oncology, Toyama Prefectural Central Hospital, 2.Department of Gastroenterology, Toyama Prefectural Central Hospital, 3.Department of Respiratory Medicine, Toyama Prefectural Central Hospital, 4.Department of Surgery, Toyama Prefectural Central Hospital)